Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin E plus Kangfuxin liquid for prevention of radiation-induced oral mucositis
ChiCTR2500110043Phase 4Recruiting
- Sponsor
- Xiangyang No.1 People's Hospital
- Start
- Sep 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of vitamin e and kangfuxin in stomatitis (4 arms), sponsored by Xiangyang No.1 People's Hospital. Primary endpoint: Time to first occurrence of radiation-induced oral mucositis. Started Sep 2025; status: recruiting.
02
Drugs
vitamin ekangfuxin
03
Conditions
stomatitis
Beyond the preview
Go deeper on ChiCTR2500110043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500110043.